A prospective, multicenter case-control study published in PLoS Medicine in 2025 described the frequency and clinical characteristics of patients with a protracted post-Covid course and searched for risk factors for persistence vs. improvement of symptoms. The analyses showed that in two thirds of the patients who had a post-Covid syndrome 6-12 months after acute SARS-CoV-2 infection, symptoms persisted in the following months.
Autoren
- Mirjam Peter, M.Sc.
Publikation
- HAUSARZT PRAXIS
Related Topics
You May Also Like
- A syndrome between decompensation and chronification
Worsening Heart Failure
- Actinic keratosis
Field-directed therapy methods: what the European guideline recommends
Opicapon: double benefit for motor function and sleep in Parkinson’s disease
- Colorectal cancer
Is exercise better than medication?
- Itching in primary biliary cholangitis
When the skin becomes agony
- TREATswitzerland Register
Evaluation of system therapies for AD
- Cardiogenic shock - 2025 update
Between standardization, team processes and targeted cycle support
- Collagenoses